Early development and growth of the laboratory reared north-east Atlantic mackerel Scomber scombrus L.

The early development, growth and morphological changes of mackerel Scomber scombrus were investigated at different incubation temperatures (8, 10, 13, 15 and 18° C). Details on the early life history are illustrated with special reference to morphological transformations. Culture techniques to rear larval mackerel stages are described using laboratory cultured foods. Artificially fertilized eggs were hatched after 80·6 h at 18·4° C and 256·8 h at 8·7° C. The standard length ( L _S) of the individuals at first feeding was 4·71 ± 0·18 mm. Four mortality critical periods and cannibalistic behaviour were identified. A maximum average larval size of 37·5 ± 4·41 mm L _S was attained 30 days post-hatch (dph) at 18·4° C. Development and growth were affected significantly by temperature during both endogenous and exogenous feeding periods. Larvae grew more rapidly at high, than at low temperatures. Daily specific growth rate (in mass) ranged from 2·4% at 10·6° C to 16·9% at 18·4° C. Likewise, average growth rate (in length) ranged from 0·05 mm day⁻¹ at 8·4° C to 0·37 mm day⁻¹ at 18·4° C. The allometric relationship of L _S, with several body measurements was not affected by temperature. Comparison with larvae collected in the Bay of Biscay did not show any significant difference in the dry mass and L _S relationship; conversely, the growth rate in length differed significantly between both laboratory and field conditions. The trends observed in the laboratory are described in relation to some aspects of the year-class strength regulation.     

红背山麻杆叶的化学成分研究(Ⅱ)——黄酮和苯乙醇苷类化合物

采用80％丙酮提取物的水萃取部位,利用凝胶、MCI、反相碳18、及 Toyopearl Butyl-650C 柱色谱进行分离纯化得到7个黄酮和3个苯乙醇苷类化合物。根据化合物的波谱数据分析鉴定为槲皮素(1)、槲皮苷(2)、异懈皮苷(3)、芦丁(4)、异牡荆素(5)、牡荆素(6)、木犀草素-7-O-α-L-鼠李糖(1→6)-β-D-葡萄糖苷(7)、2-phenethylβ-D-glucoside(8)、icariside D1(9)、2-苯乙基-D-芸香甙(10)。其中化合物1-3、5-6、8-10为首次从本属植物中分离得到。     

Temporal asynchrony and spatial co-occurrence with the host: the foraging patterns of Nemka viduata, a parasitoid of digger wasps (Hymenoptera: Mutillidae and Crabronidae)

Studies which quantitatively analyse how aculeate parasitoids exploit their window of opportunity to find and attack a host are scarce, despite the recognized importance of parasitic pressure as a driving force that promotes aggregate nesting in their hosts. We have studied the activity and behaviour of the velvet ant Nemka viduata, an ectoparasitoid of immature stages of the digger wasp Stizus continuus. Due to the resource exploited by the parasitoid (mature larvae and prepupae), and in general agreement with basic optimal foraging theory, we expected a major activity at late stages of the host seasonal provisioning period, an independence from the host daily provisioning patterns and a spatial positive association with host nest density. In accordance with these predictions, during the season, the parasitoid resulted was more active at the end of the host provisioning period, and across the day, it showed an inverse quadratic pattern of activity, in contrast to the positive one shown by the host. Thus, at both temporal scales, N. viduata activity was highly asynchronous with that of the host. At a spatial scale, however, the activity of the velvet ants was correlated with host nest density, although there is weak evidence suggesting that areas of high host density suffered from a higher rate of parasitism. Multivariate analyses confirmed a number of relevant factors associated with velvet ants’ activity, including nest density (positive), air temperature and the hour of the day (both negative). In addition, the activity of both male S. continuus and male N. viduata entered in the models in association with female parasitoid’s activity, probably because of their mating strategy.     

Orthometallated versus coordination compounds for reactions of platinum(II) and palladium(II) with the ligand benzil bis(4-methyl-3-thiosemicarbazone)

The ligand benzil bis(4-methyl-3-thiosemicarbazone) LH₂ reacts with K₂PtCl₄, both in the presence or in the absence of LiOH·H₂O, to yield simultaneously the cyclometallated mesocate [Pt₂(μ-L)₂] 1 and the coordination monomeric compound [PtL] 2, which can be easily separated by their different solubility. By contrast, reaction of Li₂PdCl₄ without base leads exclusively to the formation of the coordination compound [PdL] 3, while the use of LiOH·H₂O permits the selective synthesis of the cyclometallated mesocate [Pd₂(μ-L)₂] 4. All the complexes have been characterized by the usual techniques, including X-ray single crystal diffraction that show all the metals to be four-coordinate in a square-planar arrangement, but 2 and 3 with a N₂S₂ environment while in 1 and 4 it is CNS₂. The cytotoxic activity has been evaluated against the human lung carcinoma cell line NCI-H460, but the results show that the complexes are not active in this cell line.     

Thermal effects on growth and time to starvation during the yolk-sac larval period of Atlantic mackerel Scomber scombrus L.

The effect of incubation temperature (8·6, 11·1, 13·2, 15·1 and 16·8° C) on north-east Atlantic mackerel Scomber scombrus development, growth and age at starvation during the yolk-sac larval period was investigated. Standard length at hatch was found to be inversely proportional to incubation temperatures within the natural thermal ranges of this species; it ranged from 3·76 mm at 11·1° C to 3·30 mm at 17·8° C. Following hatch, however, larval growth rate was positively related to temperature. Individual logistic models, as a function of temperature and age, were fitted to the development processes of gape, eye pigmentation, jaw mobility and yolk exhaustion. Thereafter, development was classified into different ordered stages and an extended continuation model was fitted to the multinomial ordered stage classification. In all cases, there was a difference of >23 h between the first and the last individual developing in certain stage. The probability of survival decreased with age and was inversely related to temperature. Yolk utilization varied from 4·5 to 8·6 days and individuals died between 7·9 and 12·2 days from 17·8 to 11·1° C. The study demonstrated the significant impact that temperature has on development, growth and survival rates, during the early life history.     

Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?

Rheumatoid arthritis (RA) is associated with a similar cardiovascular risk to that in diabetes, and therefore cardiovascular risk management (CV-RM) - that is, identification and treatment of cardiovascular risk factors (CRFs) - is mandatory. However, whether and to what extent this is done in daily clinical practice is unknown. In a retrospective cohort investigation, CV-RM was therefore compared between rheumatologists and primary care physicians (PCPs). Remarkably, CRFs in RA were less frequently identified and managed by rheumatologists in comparison with PCPs. In addition, PCPs assessed CRFs less frequently in RA than in diabetes. Obviously, there is a clear need for improvement of CV-RM in RA and this should be a joint effort from the rheumatologist and the PCP.Patients with rheumatoid arthritis (RA) have an increased cardiovascular (CV) risk that appears similar to that in diabetes. This observation highlights the significant CV burden in RA. In 1999, the American Diabetes Association and the American Heart Association published a statement for prevention of CV disease in diabetes. Since then, the CV risk in diabetes has been substantially lower than in earlier decades. Given the increased CV risk in RA, screening, identification of cardiovascular risk factors (CRFs) and cardiovascular risk management (CV-RM) are also highly needed as recommended by the European League Against Rheumatism (EULAR). The increased risk in RA is attributed to systemic inflammation as well as increased prevalence of CRFs. Hence, we should aim for tight disease control and control of CRFs.Presently unknown is whether and to what extent CV-RM is translated into clinical practice. In a retrospective cohort-comprising 251 patients with RA, 251 patients with diabetes, and 251 general population individuals-Desai and colleagues therefore investigated the identification and management of CRFs by rheumatologists and primary care physicians (PCPs) [1]. RA patients had to be registered at the University of Michigan Health System for at least 12 months between June 2007 and April 2012 and had been evaluated both by their rheumatologist as well as the PCP. CRFs of interest were smoking, exercise, weight, blood pressure, lipid profile, and fasting blood glucose.In RA, PCPs identified and managed most CRFs more frequently than rheumatologists. Secondly, identification of CRFs by rheumatologists in RA patients with elevated C-reactive protein levels was not different as compared with those with normal C-reactive protein levels. A third important observation was that PCPs identified and managed CRFs more frequently in patients with diabetes, followed by general population individuals and least often in RA patients. These striking results raise several issues.First, it is hard to believe that the largely absent CV-RM by rheumatologists is explained by under-recognition because the increased CV risk in RA must presently be well known among rheumatologists. A large amount of literature on this topic has been published over the last decade. Additionally, the necessity to screen, identify, and manage CRFs is incorporated into training programmes for rheumatology residents [2]. Against this background, it is important to realise that there is a lag time between the publication of the EULAR guideline and its actual implementation (that is, the guideline was published in 2010 [3] while the current study started in 2007). In other words, CV-RM in today''s clinical practice might have been improved, but not yet recognised.Second, that the CV risk in RA is related to the inflammatory burden is well known. Nevertheless, the present study did not indicate that there is more attention for CV-RM by rheumatologists in patients with a higher inflammatory load.Third, undertreatment of the increased CV risk in RA by PCPs might be explained by under-recognition because CRFs were assessed more frequently in diabetes in comparison with RA.The EULAR guidelines recommend screening and identification of CRFs in all RA patients, and, if indicated according to CV risk-prediction charts, adequate management. As accurate assessment of CV risk depends on RA characteristics, the EULAR favoured individualising risk assessment. Hence, a risk multiplication factor of 1.5 should be used in the presence of two of the following criteria: disease duration >10 years, rheumatoid factor, and/or anti-cyclic citrullinated peptide positivity or the presence of extra-articular manifestations. However, alternative approaches have been suggested - for example, increasing the age of an RA patient by 10 years to obtain a more precise CV risk estimate or to use other risk scores. Perhaps this lack of an RA-specific CV risk-prediction model hampers CV-RM implementation. Obviously, this discussion can only be solved by developing a RA-specific CV risk-prediction model, but this will take several years to complete.One may obviously argue that, due to its retrospective design, the strength of the conclusions of Desai and colleagues may be limited; however, they are in line with other recently published literature and thus confirm extending evidence that CV-RM is poorly conducted in RA, both by rheumatologists and PCPs. Another argument against CV-RM in RA is that we should wait until trials have been conducted that demonstrate the efficacy of statins and antihypertensive agents in RA. However, it will be (many) years before specific risk models are available and withholding cardiopreventive drugs that are very likely to work also in our high-risk population is unethical. Moreover, it is important to realise that, due to the decreased incidence of CV events in the last decades, CV prevention trials are nowadays very difficult to conduct. For instance, the TRACE-RA study [4] - a large placebo-controlled double-blind primary CV prevention trial in RA with atorvastatin - was stopped prematurely owing to the very low number of CV events that occurred.Altogether, the study from Desai and colleagues provides three important clues for improvement of CV-RM in RA. First, more education is urgently needed for both rheumatologists and PCPs. Second, it is important to realise that the contribution of higher prevalence CRFs in RA is one side of the coin, but the other side is effective suppression of the inflammation. The latter is a clear task for the rheumatologist. Third, CV care of a RA patient should be a joint effort by the rheumatologist and the PCP, and they should collaborate and agree on who performs the screening, identification, and, if required, management of CRFs.     

Chronodisruption and ageing

Modern life leads to a more active nocturnal lifestyle, reduced sleep hours and sometimes abrupt shifts across time zones (such as jet lag and shift work) that generate chronodisruption (CD) which can result in premature ageing. CD is defined as a significant disturbance of the internal temporal order of biochemical, physiological and behavioural circadian rhythms. Epidemiological studies show that CD induced by shift work, chronic jet lag, social jet lag and excessive exposure of bright light at night is associated with an increased incidence of metabolic syndrome, cardiovascular disease, cognitive and affective impairment, sleep disorders, some cancers and premature ageing. CD may be the result of disturbances in different components of the circadian system (central pacemaker and peripheral oscillators, inputs to central clock, mainly due to visual deficiencies, and output signals from the pacemaker and oscillators). Exposure to different synchronizers (light, meal times, physical and social activities) with a regular pattern results in a chronoenhacement that can prevent age-related CD.